Cell volume restriction by mercury chloride reduces M1-like inflammatory response of bone marrow-derived macrophages
- 1Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan
- 2Institute of Aerospace and Undersea Medicine, National Defense Medical Center, Taipei, Taiwan
- 3School of Pharmacy, National Defense Medical Center, Taipei, Taiwan
- 4Department of Research and Development, National Defense Medical Center, Taipei, Taiwan
- 5Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
- 6Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan
A Corrigendum on
Cell volume restriction by mercury chloride reduces M1-like inflammatory response of bone marrow-derived macrophages
by Chuang Y-C, Wu S-Y, Huang Y-C, Peng C-K, Tang S-E and Huang K-L (2022). Front. Pharmacol. 13:1074986. doi: 10.3389/fphar.2022.1074986
In the published article, there was an error regarding the Affiliations for Kun-Lun Huang. As well as having affiliations 5 and 6, they should also have “1Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: aquaporin, bone marrow-derived macrophages, mercury chloride, macrophage polarization, autophagy
Citation: Chuang Y-C, Wu S-Y, Huang Y-C, Peng C-K, Tang S-E and Huang K-L (2023) Corrigendum: Cell volume restriction by mercury chloride reduces M1-like inflammatory response of bone marrow-derived macrophages. Front. Pharmacol. 14:1210999. doi: 10.3389/fphar.2023.1210999
Received: 24 April 2023; Accepted: 25 April 2023;
Published: 09 May 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Chuang, Wu, Huang, Peng, Tang and Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Kun-Lun Huang, kun@mail.ndmctsgh.edu.tw